Astronomers, both professional and backyard, know Meade Instruments Corporation (NASDAQ: MEAD) as a manufacturer and retailer of fine optical instruments, including telescopes, microscopes and binoculars. The company is still in the midst of what CEO Steve Muellner says is a "restructuring."
Revenues for both 4Q and FY 2008 are down, not significantly, but down nonetheless. The results would have been worse but for Meade's decision to sell its Simmons, Weaver and Redfield brands for $15 million in gross cash proceeds. Gross profit margins are down and FY net losses continue, only at a slightly slower pace. FY 2008 net loss was $17.7 million or $0.81 per share versus FY 2007 net loss of $19.3 million or $0.98 per share. Due to the closing of Discovery Stores, Meade Instruments took a $4 million inventory write-down.
The earnings news, while unimpressive, was not unexpected. What caused the stock to drop over 10% in trading on 16 June 2008 to close at $1.10 was a warning by auditors that there are doubts about the company's ability to continue in business. Meade senior management insists the company has the necessary cash flow to stay in business for at least the next 12 months. The company plans to introduce several new products during FY 2009 and will continue to cut costs whenever possible during the restructuring.
Last updated: February 09, 2012: 10:41 PM
Hot Stocks
DailyFinance Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
Benzinga Headlines
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
- How to Profit From Surging Chinese Prices
- Credit Suisse is the Latest Swiss Bank to Disappoint
- Vodafone Misses Quarterly Revenue
TheFlyOnTheWall.com Headlines
- Zumiez relocating ecommerce operations to Kansas
- AbitibiBowater announces termination of Fibrek's Shareholder Rights Plan
- Rockwell Medical 1.845M share registered direct offering priced at $9.50
- Activision Blizzard says Skylanders has potential to be next $1B franchise
- Activision Blizzard expects expanding non-GAAP margins in FY12
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
- Why Used Car Bargains Are Getting Harder to Find
- 5 Reasons Facebook Stock May Be a Better Buy Than You Think
- Department Stores Reveal Top Selling Valentine's Gifts
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?
Savings Experiment: Snow Removal

